CRNX
NASDAQ · Pharmaceuticals
Crinetics Pharmaceuticals In
$37.48
-6.01 (-13.82%)
Performance
1D
—
1W
—
1M
—
3M
-18.54%
6M
-9.58%
1Y
+22.16%
YTD
-19.79%
Open$43.07
Previous Close$43.49
Day High$43.31
Day Low$36.73
52W High$57.99
52W Low$25.83
Volume—
Avg Volume1.36M
Market Cap3.92B
P/E Ratio—
EPS$-4.94
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$49.40
Below
SMA 200
$38.81
Below
RSI (14)
27.9
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+31.8% upside
Current
$37.48
$37.48
Target
$49.40
$49.40
$38.77
$49.40 avg
$74.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.56M | 7.29M | 1.14B |
| Net Income | -517,998,239 | -396,663,332 | 346.78M |
| Profit Margin | -6,046.2% | -5,743.9% | 30.3% |
| EBITDA | -571,335,137 | -461,812,626 | 475.78M |
| Free Cash Flow | — | — | 205.84M |
| Rev Growth | +17.5% | +17.5% | +24.5% |
| Debt/Equity | — | — | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |